Navigation Links
OrthoGlide(TM) Medial Knee Implant Reports Over 200 Implants

Advanced Bio-Surfaces, Inc., (ABS) an orthopedic implant developer and manufacturer announced today that over 200 implants have been completed in the United States using the OrthoGlide Medial Knee implant. The OrthoGlide is a minimally invasive implant designed to relieve chronic, disabling pain, due to moderate osteoarthritis of the medial compartment of the knee.

"There has been a significant increase in the number of orthopedic surgeons interested in attending the surgeon training programs for the OrthoGlide," said Dr. Jeff Felt, Chairman and CEO of Advanced Bio-Surfaces. "The number of trained surgeons has more than doubled in the last six months, proving that orthopedic surgeons want a minimally invasive knee implant option for their patients with painful osteoarthritis of the knee.

Approximately 100 implants were performed during the first 11 months of the commercial availability of OrthoGlide. The second group of 100 implants, which brought the implant total in the United States to 200, was performed within four months. ABS is encouraged by the desire of patients and surgeons to seek an alternative that may delay the need for a total knee replacement."

Orthopaedic surgeon, Dave Trotter, M.D., President and Founder of The Center for Sports Orthopaedics in Chicago, Illinois is one of the most experienced implanters of the OrthoGlide. Dr. Trotter said, "The appeal of the OrthoGlide device is both the relative straightforwardness of the procedure and stability of the implant.

Surgeons can offer their patients pain relief, through a minimally invasive bone conserving procedure which requires no screws or cement when compared to total knee and unicompartmental replacements. This new technology can offer positive clinical outcomes to patients and provides a less invasive choice in the continuum of care."


'"/>




Page: 1

Related medicine news :

1. Implantable Contact Lens Found Safe and Effective
2. Breast Implants May Interfere With The Interpretation Of Mammogram Results
3. The Use Of Implants After Breast Cancer Questioned
4. New Implantable Device That Can Keep The Heart Ticking
5. Making MRIs Safe for Patients With Implantable Heart Devices
6. Implants In The Ear Is Effective Against All Types Of Hearing Loss
7. Minimally Invasive Ear Implant Procedures Are Better
8. Scientists Find Way To Stop Infection Of Implants
9. Implantable devices to be powered by organosilicon compounds in the future
10. Early Cochlear Implants Prove To Be Effective
11. Cell Implants May Help Those Who Suffer From Parkinsons

Post Your Comments:
(Date:12/3/2009)...e-USNewswire/ -- The American Association for Canc...e of the largest studies to date on passive smokin...thern California Cancer Center (NCCC) . ,, St...rettes and who were exposed to secondhand cigarett...od--had a significantly increased breast cancer ri...
(Date:12/3/2009)...Chiltern International Limited (Chiltern), a globa...linical development and staffing services in Europ...intment of Dr. Sharon Moore as Executive Vice Pr... Moore is based at Chiltern,s Bristol, Tennessee, ... years of industry experience. Prior to joining Ch...
(Date:12/3/2009)...wire-USNewswire/ -- The Board of Trustees of the ... voted to elect three new members during its Nov. ...-founder and Managing Director of De Novo Ventures...llion from three funds in early stage medical devi...dicus Venture Partners in 1989. He has invested in...
(Date:12/3/2009)...day has come. Eight months in the planning, delega...N organizations will gather in Phoenix Monday, Dec...,000-member National Nurses United, the largest RN...y. ,, AFL-CIO President Richard Trumka will del...l chart a course for the building of a more powerf...
(Date:12/3/2009)...wswire/ -- For California,s 3.4 million owners(1) ...s one of the most significant threats to not only ...r business,s viability. ,, "As the recession a...f small businesses are recognizing the need to sho...ability coverage," said Michael Hagedorn, CFP, C...
Breaking Medicine News(10 mins):Health News:Northern California Cancer Center's Findings on Breast Cancer and Secondhand Smoke Released Internationally by the American Association for Cancer Research 2Health News:Chiltern Names Dr. Sharon Moore as Executive VP, Global Quality & Medical Affairs 2Health News:Salk Institute Board of Trustees Elects Leaders in Venture Capital and Publishing to its Membership 2Health News:RN SuperUnion Founding Convention Opens Monday 2Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 2Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 3Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 4
...ts positive or negative emotional state has no dir...se progression, according to a large scale new stu...CER, a peer-reviewed journal of the American Cance...f whether or not the mind, through psychological s...
...t. 20 Nearly eight years of planning and,preparat...ted move from the,existing facility into the new s... one million square foot hospital brings together ...oncology and,obstetrics, the hospital offers care ...
...age of that extra hour of snooze-time, experts say... When the clocks go back an hour on the first Sund...make a small payment on your sleep debt, experts s...Stanford University Medical Center in Palo Alto, C...
... Oct. 19 Following is a statement,by Linda A. Suy...Products,Association (CHPA), regarding the recomme...ministration,s Nonprescription Drugs Advisory Comm...children., "For decades, parents and other caregi...
...ct. 19 A new survey released by the National,Alli...ic parents are,unaware of available resources for ...are of where to seek help for ADHD compared to,non...l Alliance for Hispanic Health,at: http://media.m...
... D. and Catherine T. MacArthur Foundation has prom...SF project to help combat maternal mortality in Ni...hird of all maternal deaths worldwide. , MacArth...ental organization Pathfinder International, which...
Other Medicine News:Health News:Cancer survival is not influenced by a patient's emotional status 2Health News:Northwestern Memorial Hospital Completes Move Into Its New Prentice Women's Hospital 2Health News:Northwestern Memorial Hospital Completes Move Into Its New Prentice Women's Hospital 3Health News:Fall Time Change Could Be Boon for Sleep 2Health News:Statement from the Consumer Healthcare Products Association on Today's Joint FDA Advisory Committee Recommendations Regarding Pediatric Over-the-Counter Cough and Cold Medicines 2Health News:MacArthur commits $11 million to further UCSF work in maternal safety 2Health News:MacArthur commits $11 million to further UCSF work in maternal safety 3
(Date:12/3/2009)...Dec. 3 Radiology imaging leader ME...egration capabilities at the November 2009 Radiolo...ect.PACS(TM) product, enabling the first radiolog...est release in the company,s newly branded Certeg...tp://www.newscom.com/cgi-bin/prnh/20091203/NE20631...
(Date:12/3/2009)... ParagonRx, a Delaware-based compa...and optimal medication use, will host a free webin...ce on REMS - Risk Evaluation Mitigation Strategy -...management. Dr. Gary Slatko, chief medical office...gement programs, will lead the one-hour program be...
(Date:12/3/2009)...mark and SAN DIEGO, California, December 3 /PRNews...s miR-122, a microRNA Important for,Hepatitis C Vi...patitis C,Virus in the Bloodstream in Chimpanzees ..., - SPC3649 Demonstrates Efficacy With No E... Events in the Treated Animals - Signaling a Poten...
Breaking Medicine Technology:MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5Paraplegic Takes Leap of Faith for Treatment in India 50232 1Paraplegic Takes Leap of Faith for Treatment in India 50232 2Data Demonstrates Long Term Reduction In Seizure Frequency With Novel Once Daily Anti Epileptic Zebinix 28R 29 4660 1Data Demonstrates Long Term Reduction In Seizure Frequency With Novel Once Daily Anti Epileptic Zebinix 28R 29 4660 2Data Demonstrates Long Term Reduction In Seizure Frequency With Novel Once Daily Anti Epileptic Zebinix 28R 29 4660 3Data Demonstrates Long Term Reduction In Seizure Frequency With Novel Once Daily Anti Epileptic Zebinix 28R 29 4660 4Data Demonstrates Long Term Reduction In Seizure Frequency With Novel Once Daily Anti Epileptic Zebinix 28R 29 4660 5Data Demonstrates Long Term Reduction In Seizure Frequency With Novel Once Daily Anti Epileptic Zebinix 28R 29 4660 6Data Demonstrates Long Term Reduction In Seizure Frequency With Novel Once Daily Anti Epileptic Zebinix 28R 29 4660 7Ozone depletes oil seed rape productivity 9037 1
...rine Achieves Milestone as Third Phase II Trial in...ient Enrollment and Dosing -, TUSTIN, Calif., Aug...HM ) today announced that patient screening,and do...luate the safety,and efficacy of bavituximab in co...ced breast cancer. The new trial is the second Pha...
..., Va., Aug. 8 Innocoll, Inc., a privately-held,bi...atient has been dosed,in the first of three ongoin...owned subsidiary, Innocoll Technologies Ltd, to in...for the management of,post-operative pain., Innoc...ble and fully,bioresorbable matrix of purified fib...
Other Medicine Technology:Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer 2Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer 3Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer 4Innocoll Announces Dosing of Last Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-Operative Pain 2Innocoll Announces Dosing of Last Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-Operative Pain 3Innocoll Announces Dosing of Last Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-Operative Pain 4
Premier Thumb Spica
FREEDOM® Memory Thumb Spica
QualCraft™ Gamekeeper Thumb Stabilizer
...dom® CMC ThumbFit™ reduces joint instabi...ofile splint is remarkably comfortable and easy fo... CHT and Robert V. Sypher Jr., MD, FAAOS, develope...plaints of discomfort and impaired hand function f...
Medicine Products: